Does the media refer more to AVAH or HNGE?

In the previous week, Hinge Health had 4 more articles in the media than Aveanna Healthcare. MarketBeat recorded 7 mentions for Hinge Health and 3 mentions for Aveanna Healthcare. Aveanna Healthcare's average media sentiment score of 0.95 beat Hinge Health's score of 0.46 indicating that Aveanna Healthcare is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aveanna Healthcare 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Hinge Health 3 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to AVAH or HIMS?

In the previous week, Hims & Hers Health had 27 more articles in the media than Aveanna Healthcare. MarketBeat recorded 30 mentions for Hims & Hers Health and 3 mentions for Aveanna Healthcare. Aveanna Healthcare's average media sentiment score of 0.95 beat Hims & Hers Health's score of 0.15 indicating that Aveanna Healthcare is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aveanna Healthcare 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Hims & Hers Health 3 Very Positive mention(s) 4 Positive mention(s) 23 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has stronger valuation & earnings, AVAH or CHE?

Chemed has higher revenue and earnings than Aveanna Healthcare. Aveanna Healthcare is trading at a lower price-to-earnings ratio than Chemed, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Aveanna Healthcare $2.43B 1.10 $225.03M $1.23 9.93 Chemed $2.53B 2.59 $265.24M $19.91 25.14

Does the media refer more to AVAH or CHE?

In the previous week, Chemed had 2 more articles in the media than Aveanna Healthcare. MarketBeat recorded 5 mentions for Chemed and 3 mentions for Aveanna Healthcare. Aveanna Healthcare's average media sentiment score of 0.95 beat Chemed's score of 0.22 indicating that Aveanna Healthcare is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aveanna Healthcare 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Chemed 0 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer RDNT or AVAH?

In the previous week, RadNet and RadNet both had 3 articles in the media. Aveanna Healthcare's average media sentiment score of 0.95 beat RadNet's score of 0.74 indicating that Aveanna Healthcare is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment RadNet 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Aveanna Healthcare 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor AVAH or BLLN?

In the previous week, Billiontoone had 11 more articles in the media than Aveanna Healthcare. MarketBeat recorded 14 mentions for Billiontoone and 3 mentions for Aveanna Healthcare. Aveanna Healthcare's average media sentiment score of 0.95 beat Billiontoone's score of 0.17 indicating that Aveanna Healthcare is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aveanna Healthcare 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Billiontoone 4 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Neutral

Aveanna Healthcare (AVAH) Competitors

$12.18 -0.03 (-0.25%)

Closing price 04:00 PM Eastern

Extended Trading

$12.34 +0.16 (+1.31%)

As of 07:06 PM Eastern

Compare

AVAH vs. HNGE, HIMS, CHE, RDNT, and BLLN

Should you buy Aveanna Healthcare stock or one of its competitors? Aveanna Healthcare's main competitors and comparable companies include Hinge Health (HNGE), Hims & Hers Health (HIMS), Chemed (CHE), RadNet (RDNT), and Billiontoone (BLLN). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does Aveanna Healthcare compare to Hinge Health?

Aveanna Healthcare (NASDAQ:AVAH) and Hinge Health (NYSE:HNGE) are both mid-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, media sentiment, dividends, valuation, risk, profitability, earnings and analyst recommendations.

Aveanna Healthcare presently has a consensus price target of $14.06, suggesting a potential upside of 15.12%. Hinge Health has a consensus price target of $106.00, suggesting a potential upside of 1.28%. Given Aveanna Healthcare's higher probable upside, equities research analysts plainly believe Aveanna Healthcare is more favorable than Hinge Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aveanna Healthcare	0 Sell rating(s)	5 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.67
Hinge Health	0 Sell rating(s)	3 Hold rating(s)	15 Buy rating(s)	1 Strong Buy rating(s)	2.89

Aveanna Healthcare has a beta of 1.95, meaning that its stock price is 95% more volatile than the broader market. Comparatively, Hinge Health has a beta of 1.37, meaning that its stock price is 37% more volatile than the broader market.

Aveanna Healthcare has higher revenue and earnings than Hinge Health. Aveanna Healthcare is trading at a lower price-to-earnings ratio than Hinge Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aveanna Healthcare	$2.43B	1.10	$225.03M	$1.23	9.93
Hinge Health	$587.86M	14.37	-$528.26M	$1.28	81.76

Hinge Health has a net margin of 15.15% compared to Aveanna Healthcare's net margin of 10.56%. Aveanna Healthcare's return on equity of 80.70% beat Hinge Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aveanna Healthcare	10.56%	80.70%	7.42%
Hinge Health	15.15%	51.60%	14.16%

88.0% of Aveanna Healthcare shares are owned by institutional investors. 5.3% of Aveanna Healthcare shares are owned by company insiders. Comparatively, 18.9% of Hinge Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Hinge Health had 4 more articles in the media than Aveanna Healthcare. MarketBeat recorded 7 mentions for Hinge Health and 3 mentions for Aveanna Healthcare. Aveanna Healthcare's average media sentiment score of 0.95 beat Hinge Health's score of 0.46 indicating that Aveanna Healthcare is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Aveanna Healthcare	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Hinge Health	3 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Hinge Health beats Aveanna Healthcare on 9 of the 16 factors compared between the two stocks.

How does Aveanna Healthcare compare to Hims & Hers Health?

Aveanna Healthcare (NASDAQ:AVAH) and Hims & Hers Health (NYSE:HIMS) are both mid-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, analyst recommendations, risk, media sentiment, institutional ownership, dividends, valuation and earnings.

88.0% of Aveanna Healthcare shares are held by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are held by institutional investors. 5.3% of Aveanna Healthcare shares are held by company insiders. Comparatively, 11.8% of Hims & Hers Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Aveanna Healthcare has a net margin of 10.56% compared to Hims & Hers Health's net margin of -5.51%. Aveanna Healthcare's return on equity of 80.70% beat Hims & Hers Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aveanna Healthcare	10.56%	80.70%	7.42%
Hims & Hers Health	-5.51%	-6.51%	-1.20%

In the previous week, Hims & Hers Health had 27 more articles in the media than Aveanna Healthcare. MarketBeat recorded 30 mentions for Hims & Hers Health and 3 mentions for Aveanna Healthcare. Aveanna Healthcare's average media sentiment score of 0.95 beat Hims & Hers Health's score of 0.15 indicating that Aveanna Healthcare is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Aveanna Healthcare	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Hims & Hers Health	3 Very Positive mention(s)	4 Positive mention(s)	23 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Aveanna Healthcare has higher revenue and earnings than Hims & Hers Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than Aveanna Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aveanna Healthcare	$2.43B	1.10	$225.03M	$1.23	9.93
Hims & Hers Health	$2.35B	3.06	$128.37M	-$0.63	N/A

Aveanna Healthcare has a beta of 1.95, meaning that its share price is 95% more volatile than the broader market. Comparatively, Hims & Hers Health has a beta of 2.44, meaning that its share price is 144% more volatile than the broader market.

Aveanna Healthcare currently has a consensus price target of $14.06, indicating a potential upside of 15.12%. Hims & Hers Health has a consensus price target of $32.43, indicating a potential upside of 5.49%. Given Aveanna Healthcare's stronger consensus rating and higher probable upside, research analysts clearly believe Aveanna Healthcare is more favorable than Hims & Hers Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aveanna Healthcare	0 Sell rating(s)	5 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.67
Hims & Hers Health	1 Sell rating(s)	12 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.13

Summary

Aveanna Healthcare beats Hims & Hers Health on 13 of the 17 factors compared between the two stocks.

How does Aveanna Healthcare compare to Chemed?

Aveanna Healthcare (NASDAQ:AVAH) and Chemed (NYSE:CHE) are both mid-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, profitability, media sentiment, institutional ownership, dividends, valuation and risk.

Chemed has higher revenue and earnings than Aveanna Healthcare. Aveanna Healthcare is trading at a lower price-to-earnings ratio than Chemed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aveanna Healthcare	$2.43B	1.10	$225.03M	$1.23	9.93
Chemed	$2.53B	2.59	$265.24M	$19.91	25.14

Chemed has a net margin of 10.60% compared to Aveanna Healthcare's net margin of 10.56%. Aveanna Healthcare's return on equity of 80.70% beat Chemed's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aveanna Healthcare	10.56%	80.70%	7.42%
Chemed	10.60%	31.77%	18.90%

In the previous week, Chemed had 2 more articles in the media than Aveanna Healthcare. MarketBeat recorded 5 mentions for Chemed and 3 mentions for Aveanna Healthcare. Aveanna Healthcare's average media sentiment score of 0.95 beat Chemed's score of 0.22 indicating that Aveanna Healthcare is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Aveanna Healthcare	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Chemed	0 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Aveanna Healthcare currently has a consensus target price of $14.06, indicating a potential upside of 15.12%. Chemed has a consensus target price of $554.60, indicating a potential upside of 10.82%. Given Aveanna Healthcare's stronger consensus rating and higher probable upside, research analysts clearly believe Aveanna Healthcare is more favorable than Chemed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aveanna Healthcare	0 Sell rating(s)	5 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.67
Chemed	0 Sell rating(s)	5 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.29

Aveanna Healthcare has a beta of 1.95, indicating that its stock price is 95% more volatile than the broader market. Comparatively, Chemed has a beta of 0.51, indicating that its stock price is 49% less volatile than the broader market.

88.0% of Aveanna Healthcare shares are owned by institutional investors. Comparatively, 95.9% of Chemed shares are owned by institutional investors. 5.3% of Aveanna Healthcare shares are owned by insiders. Comparatively, 3.3% of Chemed shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Chemed beats Aveanna Healthcare on 9 of the 17 factors compared between the two stocks.

How does Aveanna Healthcare compare to RadNet?

RadNet (NASDAQ:RDNT) and Aveanna Healthcare (NASDAQ:AVAH) are both mid-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, valuation, profitability, dividends, analyst recommendations, earnings, institutional ownership and risk.

Aveanna Healthcare has higher revenue and earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than Aveanna Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
RadNet	$2.27B	2.48	-$18.65M	-$0.27	N/A
Aveanna Healthcare	$2.43B	1.10	$225.03M	$1.23	9.93

RadNet has a beta of 1.41, indicating that its stock price is 41% more volatile than the broader market. Comparatively, Aveanna Healthcare has a beta of 1.95, indicating that its stock price is 95% more volatile than the broader market.

RadNet presently has a consensus price target of $90.00, suggesting a potential upside of 25.89%. Aveanna Healthcare has a consensus price target of $14.06, suggesting a potential upside of 15.12%. Given RadNet's stronger consensus rating and higher probable upside, equities analysts plainly believe RadNet is more favorable than Aveanna Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RadNet	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	2 Strong Buy rating(s)	2.89
Aveanna Healthcare	0 Sell rating(s)	5 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.67

77.9% of RadNet shares are owned by institutional investors. Comparatively, 88.0% of Aveanna Healthcare shares are owned by institutional investors. 5.1% of RadNet shares are owned by insiders. Comparatively, 5.3% of Aveanna Healthcare shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Aveanna Healthcare has a net margin of 10.56% compared to RadNet's net margin of -0.93%. Aveanna Healthcare's return on equity of 80.70% beat RadNet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
RadNet	-0.93%	2.61%	0.91%
Aveanna Healthcare	10.56%	80.70%	7.42%

In the previous week, RadNet and RadNet both had 3 articles in the media. Aveanna Healthcare's average media sentiment score of 0.95 beat RadNet's score of 0.74 indicating that Aveanna Healthcare is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
RadNet	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Aveanna Healthcare	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Aveanna Healthcare beats RadNet on 12 of the 16 factors compared between the two stocks.

How does Aveanna Healthcare compare to Billiontoone?

Aveanna Healthcare (NASDAQ:AVAH) and Billiontoone (NASDAQ:BLLN) are both mid-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, earnings, media sentiment, valuation, analyst recommendations, risk, dividends and profitability.

Aveanna Healthcare currently has a consensus price target of $14.06, suggesting a potential upside of 15.12%. Billiontoone has a consensus price target of $126.25, suggesting a potential upside of 35.65%. Given Billiontoone's higher possible upside, analysts plainly believe Billiontoone is more favorable than Aveanna Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aveanna Healthcare	0 Sell rating(s)	5 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.67
Billiontoone	1 Sell rating(s)	3 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.55

In the previous week, Billiontoone had 11 more articles in the media than Aveanna Healthcare. MarketBeat recorded 14 mentions for Billiontoone and 3 mentions for Aveanna Healthcare. Aveanna Healthcare's average media sentiment score of 0.95 beat Billiontoone's score of 0.17 indicating that Aveanna Healthcare is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Aveanna Healthcare	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Billiontoone	4 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Neutral

Aveanna Healthcare has a net margin of 10.56% compared to Billiontoone's net margin of 8.04%. Aveanna Healthcare's return on equity of 80.70% beat Billiontoone's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aveanna Healthcare	10.56%	80.70%	7.42%
Billiontoone	8.04%	9.96%	5.35%

88.0% of Aveanna Healthcare shares are owned by institutional investors. 5.3% of Aveanna Healthcare shares are owned by company insiders. Comparatively, 50.2% of Billiontoone shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Aveanna Healthcare has higher revenue and earnings than Billiontoone. Aveanna Healthcare is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aveanna Healthcare	$2.43B	1.10	$225.03M	$1.23	9.93
Billiontoone	$305.11M	14.39	$7.45M	$0.70	132.96

Summary

Aveanna Healthcare beats Billiontoone on 10 of the 16 factors compared between the two stocks.

Get Aveanna Healthcare News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AVAH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

AVAH vs. The Competition

Export

Metric	Aveanna Healthcare	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$2.66B	$10.03B	$7.15B	$13.16B
Dividend Yield	N/A	2.61%	2.52%	20.73%
P/E Ratio	9.90	33.77	275.97	25.79
Price / Sales	1.09	4.82	615.58	101.37
Price / Cash	17.76	22.64	27.30	36.12
Price / Book	13.10	5.14	10.68	6.03
Net Income	$225.03M	$315.68M	$3.50B	$380.34M
7 Day Performance	-0.33%	-1.03%	-3.18%	-3.04%
1 Month Performance	-13.49%	-2.93%	-6.61%	-5.16%
1 Year Performance	38.10%	11.33%	3.69%	-2.48%

Aveanna Healthcare Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
AVAH Aveanna Healthcare	4.5487 of 5 stars	$12.18 -0.2%	$14.06 +15.4%	+41.2%	$2.66B	$2.43B	9.90	35,500	Positive News
HNGE Hinge Health	2.302 of 5 stars	$98.27 -0.1%	$105.33 +7.2%	+110.7%	$7.93B	$720.06M	76.78	1,437	Analyst Forecast Gap Up
HIMS Hims & Hers Health	1.8737 of 5 stars	$29.47 -0.7%	$32.43 +10.1%	-43.0%	$6.87B	$2.58B	N/A	2,442	Trending News Gap Down
CHE Chemed	4.4375 of 5 stars	$510.36 -0.2%	$554.60 +8.7%	+16.6%	$6.67B	$2.53B	25.63	15,811	Analyst Upgrade
RDNT RadNet	3.7515 of 5 stars	$70.28 -0.4%	$90.00 +28.1%	+1.3%	$5.53B	$2.04B	N/A	11,264

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:AVAH) was last updated on 10/13/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Aveanna Healthcare (AVAH) Competitors

AVAH vs. HNGE, HIMS, CHE, RDNT, and BLLN

How does Aveanna Healthcare compare to Hinge Health?

Summary

How does Aveanna Healthcare compare to Hims & Hers Health?

Summary

How does Aveanna Healthcare compare to Chemed?

Summary

How does Aveanna Healthcare compare to RadNet?

Summary

How does Aveanna Healthcare compare to Billiontoone?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AVAH vs. The Competition

Aveanna Healthcare Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Aveanna Healthcare (AVAH) Competitors

AVAH vs. HNGE, HIMS, CHE, RDNT, and BLLN

How does Aveanna Healthcare compare to Hinge Health?

Do analysts rate AVAH or HNGE?

Which has more volatility & risk, AVAH or HNGE?

Which has higher valuation and earnings, AVAH or HNGE?

Is AVAH or HNGE more profitable?

Do insiders & institutionals hold more shares of AVAH or HNGE?

Does the media refer more to AVAH or HNGE?

Summary

How does Aveanna Healthcare compare to Hims & Hers Health?

Do institutionals & insiders believe in AVAH or HIMS?

Is AVAH or HIMS more profitable?

Does the media refer more to AVAH or HIMS?

Which has stronger earnings and valuation, AVAH or HIMS?

Which has more volatility and risk, AVAH or HIMS?

Do analysts rate AVAH or HIMS?

Summary

How does Aveanna Healthcare compare to Chemed?

Which has stronger valuation & earnings, AVAH or CHE?

Is AVAH or CHE more profitable?

Does the media refer more to AVAH or CHE?

Do analysts prefer AVAH or CHE?

Which has more volatility and risk, AVAH or CHE?

Do insiders & institutionals believe in AVAH or CHE?

Summary

How does Aveanna Healthcare compare to RadNet?

Which has higher valuation and earnings, RDNT or AVAH?

Which has more volatility and risk, RDNT or AVAH?

Do analysts recommend RDNT or AVAH?

Do insiders and institutionals hold more shares of RDNT or AVAH?

Is RDNT or AVAH more profitable?

Does the media prefer RDNT or AVAH?

Summary

How does Aveanna Healthcare compare to Billiontoone?

Do analysts prefer AVAH or BLLN?

Does the media favor AVAH or BLLN?

Is AVAH or BLLN more profitable?

Do insiders & institutionals hold more shares of AVAH or BLLN?

Which has preferable earnings and valuation, AVAH or BLLN?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AVAH vs. The Competition

Aveanna Healthcare Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools